IMMUNOTOXICOLOGYSpecialty Section
Summer Edition
2017-2018
Executive Committee
President
Victor J. Johnson
Vice President
Jamie DeWitt
Vice President-Elect
Emanuela Corsini
Secretary/Treasurer
Stacey Anderson
Past President
L. Peyton Myers
Senior Councilor
Rodney Prell
Junior Councilor
Jessica Lynch
Postdoc Representative
Angela Groves
Student Representative
Jiajun (Brian) Zhou
The Immunotoxicology Specialty
Section (ITSS) Newsletter ispublished three times a year
(Summer, Fall, and Winter). If you
would like to share an item of interest
with members of the ITSS, please
send it to the Communications
Committee Chair. All comments andsuggestions are welcome.
Jiajun (Brian) Zhou
zhoujiaj@msu.edu
Angela Groves
Angela_Groves@URMC.
Rochester.edu
Jessica Lynch
jlynch18@ITS.JNJ.com

June 2017

Incoming President’s Message
Greetings fellow Immunotoxicologists! It is hard to believe that 2017 isin full swing, another exciting and stimulating SOT meeting is under
our belts, and, at the time of writing this note, the 2017 Stanley Cup
Playoffs just finished, Congrats Penguins (had to put that out there for
the ITSS hockey fans!). It seems not long ago that I joined SOT and ITSS
as a student member; actually it was 1998 so technically it was a whileago. It is with great honor and dedication that I will serve the ITSS
membership as incoming President for the 2017-2018 term. For thosemembers that are less familiar with me, my career in
Immunotoxicology began under the mentorship of Drs. Barry Blakely
and Chatur Sisodia at the University of Saskatchewan (MSc) and Dr.
Raghubir Sharma at the University of Georgia (PhD). Following my
PhD, I was blessed to work under the mentorship of one of
Immunotoxicology’s founding fathers, Dr. Michael Luster, at
NIOSH/CDC. I was later recruited by Burleson Research Technologies(BRT) where I have been working with Drs. Gary and Florence
Burleson for nearly 6 years investigating immunotoxicity safety andrisk assessment. Since 2014, I have been serving as the Principal
Investigator for Immunotoxicology for the National Toxicology
Program (NTP) providing leadership for the NTP Contract awarded to
BRT and have the pleasure of working with the leadership of Dr. Dori
Germolec, NTP Group Leader for Systems Toxicology.
OK, enough about me already! Sincere thanks go out the last year’s
ITSS Executive Committee and the leadership provided by Dr. Peyton
Myers, outgoing ITSS President. You were a great group to work with,the past year was fun. Peyton, you are not getting away that easy, we
still have monthly teleconferences and check out goal 4 below.
What’s inside?
President’s Message…………..…………………………………….……1
Outgoing President’s Message…………………………………………4
Student Post-doctoral Committee Report ……..........……....….…..5
2017 ITSS Award Winners…………...….…….......……….……….......6
Member Spotlight: Peyton Myers....................................................102017 ITSS Committee Lists…………...............................................12
Job Opportunity................................................................................13
Program…………...............................................................................14
Recent Immunotoxicology Publications........................................15
1

Immunotoxicology Specialty Section

President’s Message, continued:
I would also like to welcome the new members to the
Executive Committee, Dr. Emanuela Corsini (VicePresident-Elect), University of Milan, and Dr. Jessica
Lynch (Junior Councilor), Janssen Research &,Development and Dr. Stacey Anderson (Secretary/Treasurer), NIOSH/CDC. The ITSS
Executive Committee also sends thanks to the subcommittees and their volunteers, including
Education, Membership, Awards, and Program. Thanks for all the hard work!
The 2017-2018 year will be busy for the ITSS Executive Committee. We want to build off thesuccesses from last year and continue to improve the caliber of the specialty section and its
impact and visibility within toxicology. I would like to take an opportunity to highlight a few goals
for ITSS for the coming year.
Goal 1: Identify and/or create educational opportunities for ITSS membership. Education
opportunities have an important impact on the strength of the discipline of immunotoxicology
and of the ITSS. This includes training opportunities for graduate students and postdocs aswell as continuing education. The old adage, “It is never too late to teach an old dog a newtrick,” is certainly applicable. We need to continue to strive for new knowledge in order to makenovel advances in the field. The ITSS Executive Committee and the Education Sub-committee
strives identifying, and/or creating/co-organize training opportunities that will improve theknowledge-base for membership as well as provide visibility and understanding of our field of
toxicology. This past year, ITSS co-sponsored a workshop with ILSI/HESI entitled “T-cell
Biology and Application to Immunopharmacology and Immunotoxicology Course” held at
MedImmune in Gaithersburg, MD on April 18-19, 2017. This course was a resounding successwith much positive feedback from attendees, expert lecturers, and organizers. The ITSS
Executive Committee will look to continue similar efforts and collaborations in the coming year.
Additional mechanisms for learning include webinars developed by ITSS membership andhosted by ITSS as well as webinars and courses/meeting hosted by other profession societies
in related disciplines. We will work hard to identify educational opportunities and translate themto the membership. A shout to all ITSS members, if you find a course or webinar or othertraining tool, please bring this to the attention of the ITSS Executive Committee [email to Jamie
DeWitt (DEWITTJ@ecu.edu), Education Chair or Vic Johnson (vjohnson@brt-labs.com) sothat we can help spread the word.
Goal 2: Foster International Scientific Exchange and Collaboration. The ITSS has a longstanding relationship with the Japanese Society of Immunotoxicology (JSIT). This partnershipwas established in 2005 to provide a vehicle for exchange of science and education on aninternational level. This program has been extremely successful and had lead to cutting-edge
scientific presentations given by ITSS members at the JSIT meeting and reciprocalpresentation of cutting-edge science by JSIT members at the SOT meeting. We are proud tocontinue this relationship and to expand the communication between ITSS and JSIT.
Reciprocal publications in respective newsletters is now an ongoing strategy to share ideas
and accomplishments throughout the year. Building on the success of the ITSS-JSIT
collaboration, the ITSS Executive Committee is expanding outreach to additional nations. At
the present time, discussions are ongoing with immunotoxicology experts in European andAsian nations with the vision of establishing feasible mechanisms for international colorationand sharing of science.
June 2017

2

Immunotoxicology Specialty Section

President’s Message, continued:
Goal 3: Solidification of Endowment Fund. I will speak for the entire ITSS membership in
thanking Drs. Prakesh and Mitzi Nagarkatti for their gracious donation that established a new
ITSS Endowment Fund, now known as the “Mitzi and Prakash Nagarkatti Research Excellencein Immunotoxicology Award Fund”. This fund is designed to encourage and recognize graduate
students and postdoctoral scholars for their excellence in research involving mechanisms of
immunomodulation in health and disease. The fund will provide travel awards for graduate
students and postdoctoral scholars to attend the SOT meeting providing them the opportunity
to present their research, gain valuable feedback from peers, learn cutting-edge science, andbuild a network. In order to make this endowment fund permanent and receive matching funds
from SOT, ITSS needs to raise $15,000 to bring the fund to $25,000, at which point, SOT will
provide an additional $25,000 and make the fund permanent. Please reach out to the ITSS
Executive Committee if you are interested in contributing this valuable fund. SOT has made iteasy for members to contribute to the endowment. Please follow this link (https://www.aimhq.com/netforumsot/eweb/DynamicPage.aspx?WebCode=AddDonation&Action=Add&Site=SOT) and scroll to find the “Mitzi and Prakash Nagarkatti Research Excellence in
Immunotoxicology Award Fund”. Any and all contributions are welcome and greatly
appreciated.
Goal 4: Tap into the resource that is The ITSS Past Presidents. The leadership of the ITSS
have a wealth and breadth of knowledge and expertise that should not go untapped. These
individuals were gracious in volunteering to lead ITSS at some point in their career and thecurrent ITSS Executive Committee (as well as the committees of recent years) challenge the
Past Presidents to stay involved and allow us to continue to benefit from their expertise andwisdom. As such, the Science Advisory subcommittee will be formalized under ITSS and will
be tasked with reaching out to the Past Presidents and engaging them in scientific discussions
that will benefit the membership. One excellent opportunity that comes to mind is a discussion
about future hot topics and creating seeds for program proposals. This will help foster thescience that ITSS wants to represent at future meeting. Past Presidents, be ready, keep an
open mind, and let’s see where this can take us in our pursuit of everything that is
Immunotoxicology.
On behalf of the 2017-2018 ITSS Executive Committee, we look forward to working for themembership for the coming year. We welcome and encourage any and all interactions withITSS members with the goal of making the specialty section inviting, productive, and visible.
Dr. Vic Johnson
President, ITSS
2017 - 2018

June 2017

3

Immunotoxicology Specialty Section

Outgoing President’s Message:
Time really does fly. It seems like it was only yesterday that I was writing the incoming
President’s message and started the task of planning the ITSS Program for 2017. Here it is ayear later and I don’t know where the time went!
It has been a great honor to serve as the President of the Immunotoxicology Specialty Section
during the 2016-2017 term. I have enjoyed working with the members in ITSS over my many
years in ITSS. I especially appreciate the dedicated work of the Executive Committee. Runninga Specialty Section is only possible with the hard work and effort of the Executive Committee. I
have sincerely enjoyed working with such dedicated people.
I hope that the efforts we expanded in the last couple of years will continue to be a success.
We had a productive meeting in Baltimore and I know that the current Executive Committee isworking diligently to make San Antonio a success. The international collaborations with JSIT
and Europe are strong and will continue to grow under Vic, Jamie, and Emanuela.
Furthermore, our collaboration with ILSI/HESI (which coalesced into the T-cell workshop)
appears to be continuing with a repeat of the course in Europe before returning to the US thefollowing year. Lastly, we were honored to have seed money donated to help establish asecond Endowment Fund for ITSS. We have three years to collect the remaining minimum
moneys to establish the fund as permanent within SOT. I have no doubt that the community will
step up with donations and the fund will be established. The ITSS community always amazes
me with its commitment to its members.
It was a great honor to serve as the President of ITSS from 2016-2017. I am sure that ITSS isin great hands and I look forward to a great success in 2018 and years to come.
Dr. Laine Peyton Myers
Past-President, ITSS 2016 - 2017

June 2017

4

Immunotoxicology Specialty Section

Student & Postdoctoral Report:
Dear graduate students and postdocs,
I hope you are having a fun and productive summer so far.
I would like to thank everyone who participated in the Graduate Student/Postdoc Mixer and the
3rd Annual Networking Event hosted by the Immunotoxicology Specialty Section at the 56th
Annual SOT Meeting in Baltimore, Maryland. We had a great turnout at the Graduate
Student/Postdoc Mixer and our poster was well attended. We also had about 25 people
participate in the Networking Event. At the Networking Event the participants had theopportunity to interact with diverse panelists from academia, industry and government. The
participants were able to connect with these experts to learn about what it is like to hold theirpositions and ask advice on career planning. We were happy to have received much positive
feedback from the participants. Additionally, about half of the participants were non-ITSS
members, indicating that the event was well advertised and students and postdocs werelooking for more career development events within SOT. The feedback we received has beenvery helpful, and it will help us to make adjustments for next year’s event.
We also encourage the ITSS graduate student and postdoc members to become involved
with us by participating in the ITSS committees. This is a great way to connect with other
ITSS members and to enhance your professional network. There are 4 different committees
within ITSS: Awards, Program, Education and Communication/Membership, each chaired byfriendly and motivated members of the ITSS executive committee. Participating in these
activities can be rewarding and it is also great opportunity to get to know theimmunotoxicological community. If you would like to get more involved please contact us atAngela_Groves@URMC.Rochester.edu or zhoujiaj@msu.edu.
We look forward to working with you!
Angela Groves, Ph.D.
Jiajun (Brian) Zhou

June 20175

Immunotoxicology Specialty Section

2017 ITSS Award Winners:
Vos Award for Lifetime Career Achievement in Immunotoxicology
The Vos Award for Lifetime Career Achievement in Immunotoxicology is presented to anindividual in recognition of career achievements in advancing the field of immunotoxicology
through service, leadership, and scientific contributions.

Dr. Dori Germolec
National Toxicology Program
National Institute of Environmental Health
Sciences
Immunology Discipline Leader
Group Leader, Systems Toxicology
Nominated by:
Dr. Bob Luebke
Dr. Jamie DeWitt
Dr. Kristen Ryan

Outstanding Senior Investigator Award
The Outstanding Senior Investigator Award is presented to an individual whose work has
made significant contributions to the field of Immunotoxicology. This award is for scientists inacademia, industry, or those who have had an impact on regulatory issues, and has
distinguished themselves as leaders in their chosen area of immunotoxicology.

Dr. Steve Pruett
Mississippi State University
Professor
Department of Basic Sciences
College of Veterinary Medicine
Nominated by:
Dr. Deborah Keil

2017 ITSS Award Winners :Outstanding Young Investigator Award
The Outstanding Young Investigator Award is presented to an individual whose work has madesignificant contributions to the field of Immunotoxicology. This award is for scientists inacademia, industry, or those who have had an impact on regulatory issues, having 10 years orless of experience since obtaining their highest degree.

Dr. Robert Li
GenentechPharmacology Sub-team Leader
Safety Assessment and Development Sciences
Nominated by:
Dr. Hong Wang and Dr. Rodney Prell

Health and Environmental Sciences Institute (HESI) Immunotoxicology
Young Investigator Travel Award

Dr. Anthony Franchini
University of Rochester
Identification of novel gene targets of the arylhydrocarbon receptor in dendritic cells in thecontext of viral infection.
A.M. Franchini, J.R. Myers, G.B. Jin and B.P.
Lawrence
Nominated by: Dr. B. Paige Lawrence2017 ITSS Award Winners:
Best Paper of the Year

Silica-Triggered Autoimmunity in
Lupus-Prone Mice Blocked by
Docosahexaenoic Acid
Consumption
PLOS One: 0160622 published ahead ofprint August 11, 2016
Melissa Bates, Christina Brandenberger,
Ingeborg I. Langohr, Kazuyoshi Kumagai, Adam
L. Lock, Jack R. Harkema, Andrij Holian andJames J. Pestka

Best Presentation by a Postdoctoral Trainee Award

Dr. Anthony Franchini
University of Rochester
Identification of novel gene targets of the arylhydrocarbon receptor in dendritic cells in thecontext of viral infection.
A.M. Franchini, J.R. Myers, G.B. Jin and B.P.
Lawrence
Nominated by: Dr. B. Paige Lawrence

Best Presentation by a Student AwardFirst Place

Second Place

Jessica Meyers

Alastair Mak

University of Rochester

University of Toronto

Aryl hydrocarbon receptor activation during
development reduces dendritic cell function laterin life.

Distinguishing the potential of chemically similardrugs to cause IDILI in an impaired immune
tolerance model.

Nominated by: Dr. B. Paige Lawrence

Nominated by: Dr. Jack Uetrecht

Joseph Henriquez

Third Place

Jiajun (Brian) Zhou

Michigan State University

Michigan State University

Delta-9-tetrahydrocannabinol (THC) suppresses
interferon-α (IFNα) mediated activation of healthyand HIV infected T cells.

Suppression of IgM response by 2,3,7,8tetrachlorodibenzo-p-dioxin (TCDD) involves
impairment of immunoglobulin secretion byhuman primary B cells.

Nominated by: Dr. Norbert Kaminski

Nominated by: Dr. Norbert Kaminski

Member Spotlight: Dr. Peyton Myers
Dr. Laine Peyton Myers is a toxicologist at the US Food and Drug Administration and has justfinished his tenure as ITSS President for the 2016-2017 term.
When did you begin your career in immunotoxicology?
I began my career in imunotoxicology in the summer of 1997 in Steve Pruett’s lab at LSU in
Shreveport, LA. Steve (also a former ITSS President) was my undergraduate advisor and hadtaught my immunology course at Mississippi State University. Steve offered me a position in
his new lab at LSU to work with his group looking at the immunotoxicity of alcohol in a binge
drinking model as well as the immunotoxicity of various herbicides and pesticides. It was anamazing time for research and collaboration. It was in Steve’s lab that I attended both my firstregional SOT meeting as well as my first SOT meeting as a student in Philadelphia, PA in
2000. My first SOT meeting was very daunting! There were so many people asking questions
and so many presentations. It is a very different feeling nowadays going to SOT andreminiscing with old friends.
When did you start participating in the ITSS?
I was encouraged by Steve to get involved in SOT in order to establish a network. When thestudent position became open (maybe 2001?), I applied to the graduate student position.
Susan McKarns was rolling off as the student representative and I took up the mantle. It was
so interesting to see how the executive committee worked and who the senior leaders in thefield were.
What was you most rewarding experience involving ITSS?
I think the most rewarding experience was the opportunity to represent ITSS in Japan at the
JSIT annual meeting in 2013. The cultural exchange between ITSS and JSIT is a wonderful
opportunity to present data, exchange ideas, and experience another culture. I will always be
grateful to Mitch and Kazu for making the exchange happen.
What was your experience as the President for ITSS?
Being President was an incredible experience. First, it was rather humbling to be in the position
that had been occupied by so many of my mentors in the field. I had big shoes to fill and I hope
I served the community well. Second, I greatly enjoyed working with the Executive Committee.
The folks on the Executive Committee are dedicated to making ITSS a better place. It is so
great to get to work with such dedicated folks.

June 201710

Immunotoxicology Specialty Section

Member Spotlight, continued:
What motivated you to be a part of ITSS?
After my stint as student rep, I continued as postdoc rep, and then I was hooked. ITSS is afamily. If you have ever heard of the “six degrees of separation”, well I used to say ITSS isbasically 2 degrees of separation. Many of the pioneers in immunotoxicology started back in
the Medical College of Virginia and thus most of us who trained under the pioneers are likefamily. A big, crazy family, but a family nonetheless.
Is that anything you would like to change in ITSS?
The only thing I’d like to do would be to add more social time with each other at the annual
meeting. As SOT has grown in size, it has grown more compressed with meetings on top of
meetings. I do miss having time to socialize with colleagues and catch up with everyone.
Maybe since Vic has taken over as President, I’ll have more time!
You mentioned that you were once the postdoc representative for the ITSS. What was
the most challenging aspect of transitioning out of a student role and into leadership?
An early challenge in the transition from student to leadership initially was seeing thecolleagues (who had until that point been mentors or superiors) as colleagues. That is atransition that all scientists have to undergo. It is still hard calling some of my original mentors
by their first name (instead of Dr. “X”). Other than that minor awkwardness, the bureaucracy ofrunning a committee or learning new leadership concepts was likely the biggest challenge.
Scientists are trained to think of concepts, analyze data, and postulate theories. Graduate
school is not designed to equip the future science community with many leadership tools.
Luckily many employers offer leadership training that can benefit young scientists. If yourpostdoc or first job offers leadership training, I’d suggest that you take advantage of theopportunity to learn new skills.
What has been the largest benefit, for you, of being an active participant in an SOT SS
like the ITSS?
The largest benefit was that I got to meet great people in ITSS. Along those lines, I cannot
thank a small cadre of colleagues in ITSS (you know who you are) that helped my career when
I needed advice and opportunities. My career path to-date is directly associated with theunique and helpful people I met in ITSS. The connections I made in ITSS have helped bothwith my career as well as personally.
Do you have any advice for someone who is considering becoming more involved in an
SS or SIG?
Volunteer! Try to get elected to a position, but even if you don’t get elected, get involved. There
are always positions on committees that need help. Also, if you volunteer, make sure tocomplete whatever assignment you have on the committee. Your next employer may be on thecommittee, and if they see you failing to complete an assignment, it may affect your job
prospects. On the other hand, if they see you complete your tasks with gusto, then it may open
up a future career path!
Dr. Laine Peyton Myers
Past President, ITSS 2016 - 2017
June 201711

Immunotoxicology Specialty Section

2017 ITSS Committee List:
Program Committee
Chair: Jamie DeWitt
Emanuela Corsini
Sarah Blossom
Mark Collinge
M. Firoze Khan
Robert Li
Joanna Matheson
Michelle Miller
Gautham Rao
Berran Yucesoy

New!
Scientific Advisory Committee
Chair: Peyton Myers
Victor Johnson
Jamie DeWitt
Emanuela Corsini

Volunteers Needed for Limited Number of Seats:
Please contact the committee chairs if you are interested.

Education Committee
Chair: Emanuela Corsini
emanuela.corsini@unimi.it

Awards Committee
Chair: Rodney Prell
prell.rodney@gene.com

Communication andMembership Committee
Chair: Jessica Lynch
jlynch18@ITS.JNJ.com

June 2017

Note:
SOT membership is required.
Must be willing to become a memberof the ITSS and to commit to service.

12

Immunotoxicology Specialty Section

Job Opportunity:
Postdoc Position with CDC/NIOSH, Morgantown, WV
OPEN POSITION:
The National Institute for Occupational Safety and Health (NIOSH) is pleased to announce an opening
for an Associate Service Fellow in the Allergy and Clinical Immunology Branch (ACIB) within the Health
Effects Laboratory Division (HELD), located in Morgantown, WV. ACIB is a research-oriented branch
studying the immunological effects of occupational exposures. The selected candidate’s research will
focus the identification of novel mediators of chemical induced allergic disease, including the
microbiome. This position is a three-year, postdoctoral fellowship, with the potential for renewal based
upon performance and available NIOSH funding.
RESPONSIBILITES:
The successful candidate will work under the direction of Stacey Anderson, PhD and conduct researchthat addresses the immunotoxicological effects of occupational chemicals using in vitro and in vivo
models in addition to clinical samples. The selected candidate will be expected to write reports,
proposals, train students, work efficiently with other lab members and collaborators, present findings
at local and international meetings, and publish research findings in peer reviewed journals.
QUALIFICATIONS:
The following qualifications are required for this position:• A background in cell biology, toxicology and/or immunology.
• Experience with tissue culture, immunological assays, and flow cytometry is expected• Excellent scientific writing ability, strong oral communication skills, and the ability to work
effectively and collegially.
• The applicant must be able to function in a team environment and work independently andcollaborate with team members and external researchers• The following qualifications are considered highly desirable for this position:• A Ph.D. or equivalent degree (M.D., ScD., D.V.M., etc.) in immunology, toxicology or another related
discipline from an accredited university.
• Experience in animal studies, next generation sequencing, and bioinformatics would be beneficial,
but not necessary• A strong publication record.
• Proficient ability with Microsoft Office, Word, Excel and PowerPoint is desirable
Candidates at an early or advanced stage of postdoctoral training are encouraged to apply. Salary isdependent upon academic degree and experience (salary range starting at $60,210). Health andretirement benefits are included.

June 201713

Immunotoxicology Specialty Section

Job Opportunity, continued:
FACILITIES:The NIOSH research campus in Morgantown is adjacent to West Virginia University; metropolitan areas
in Pittsburgh and Washington DC are within a one and three hour drive, respectively.
http://www.cdc.gov/niosh/contact/im-held.html
NIOSH is an Affirmative Action/Equal Opportunity Employer.
APPLICATION:
Please send a cover letter, your curriculum vitae, a brief statement of your research interests, andcontact information of three references via e-mail to:
Stacey Anderson, PhD
Team Leader/Research Biologist
NIOSH/HELD/ACIB
1095 Willowdale Road, MS L4020
Morgantown, WV 26505
Sanderson4@cdc.gov

Program:Is the study of the immunotoxic effects of exogenous agents a thing of the past? It appeared
so to the 2017-2018 ITSS Program Committee. After last year’s nearly record-setting numberof proposal submissions for the 2017 SOT Annual Meeting, this year’s program committee
was surprised that we received only FIVE proposals for pre-review and only THREE proposals
for formal endorsement. What happened ITSS members? Were you so overwhelmed with theamazing programs from the 2017 Annual Meeting that you thought endorsement would be
similar to getting published in a top tierjournal…a long-shot? It’s not a long-shot and thenumber of submissions sends a message of theimportance of our Specialty Section discipline tothe leaders of SOT! Please make the 2019
Annual Meeting heavy on immunotoxicology andconsider submitting a program proposal for thatmeeting. You have a year to plan! Otherwise, wewill highlight presentations by ITSS members in
the newsletter that we send out immediately
prior to the Annual Meeting so that you can
support your ITSS colleagues.
Jamie DeWitt
Vice President, 2017-2018
June 201714

Immunotoxicology Specialty Section

Recent Immunology Publications:
Compiled by Angela Groves and Jiajun (Brian) Zhou. Anytime you have a new fully-publishedor electronically available article to report, please send the citation to Angela atangela_groves@urmc.rochester.edu.
Asthma, Allergy, Autoimmunity & Hypersensitivity
Di Gioacchino, M., Di Giampaolo, L., D’Ambrosio, V., Martino, F., Cortese, S., Gatta, A., Della
Valle, L., Farinelli, A., Mangifesta, R., Cipollone, F. and Niu, Q., 2017. Allergens in
Occupational Allergy: Prevention and Management–Focus on Asthma. In Allergy and
Immunotoxicology in Occupational Health (pp. 47-62).
Dobashi, K., 2017. Traditional and Emerging Occupational Asthma in Japan. In Allergy and
Immunotoxicology in Occupational Health (pp. 83-91).
Filon, F.L., 2017. Skin Exposure to Nanoparticles and Possible Sensitization Risk. In Allergy
and Immunotoxicology in Occupational Health (pp. 143-152).
Murgia, N., Folletti, I., Paolocci, G., dell’Omo, M. and Muzi, G., 2017. Non‐industrial Indoor
Environments and Work‐Related Asthma. In Allergy and Immunotoxicology in Occupational
Health (pp. 103-114).
Niu, Q. and Zhang, Q., 2017. Combined Effect on Immune and Nervous System of Aluminum
Nanoparticles. In Allergy and Immunotoxicology in Occupational Health (pp. 115-128).
Petrarca, C., Di Giampaolo, L., Pedata, P., Cortese, S. and Di Gioacchino, M., 2017.
Engineered Nanomaterials and Occupational Allergy. In Allergy and Immunotoxicology in
Occupational Health (pp. 27-46).
Developmental Immunotoxicolgy
Gilbert, K.M., Bai, S., Barnette, D. and Blossom, S.J., 2017. Exposure Cessation During
Adulthood Did Not Prevent Immunotoxicity Caused by Developmental Exposure to Low-Level
Trichloroethylene in Drinking Water. Toxicological Sciences, 157(2), pp.429-37. .
Ohta, R., Ohmukai, H., Negura, T., Tazura, Y. and Shindo, T., 2017. Normal ovarian aging, but
modified T-cell differentiation, in female mice following neonatal exposure to bisphenol A.
Fundamental Toxicological Sciences, 4(1), pp.15-21.
General Immunotoxicology
Ahmed, T., Goel, V. and Banerjee, B.D., 2017. Propoxur-induced oxidative DNA damage inhuman peripheral blood mononuclear cells: protective effects of curcumin and α-tocopherol.
Drug and Chemical Toxicology, pp.1-7.
Baker, A.H., Wu, T.H., Bolt, A.M., Gerstenfeld, L.C., Mann, K.K. and Schlezinger, J.J., 2017.
Tributyltin Alters the Bone Marrow Microenvironment and Suppresses B Cell Development.
Toxicological Sciences.
June 201715

Immunotoxicology Specialty Section

Recent Immunology Publications:
General Immunotoxicology, cont.
Baker, A.H., Wu, T.H., Bolt, A.M., Gerstenfeld, L.C., Mann, K.K. and Schlezinger, J.J., 2017.
Tributyltin Alters the Bone Marrow Microenvironment and Suppresses B Cell Development.
Toxicological Sciences.
Bastan, R., Eskandari, N., J. Ardakani, H. and T. Peachell, P., 2017. Effects of fostriecin on
β2-adrenoceptor-driven responses in human mast cells. Journal of immunotoxicology, 14(1),pp.60-65.
Johnson, V.J., Auerbach, S.S., Luster, M.I., Waidyanatha, S., Masten, S.A., Wolfe, M.S.,
Burleson, F.G., Burleson, G.R., Germolec, D.R., 2017. Evaluation of 4methylcyclohexanemethanol (MCHM) in a combined irritancy and Local Lymph Node Assay(LLNA) in mice. Food and Chemical Toxicology, 105:99-105.
Kountouras, J., Polyzos, S.A., Katsinelos, P., Tzivras, D., Boziki, M., Gavalas, E., Zavos, C.,
Vardaka, E., Romiopoulos, I., Anastasiadis, S. and Tsiaousi, E., 2017. Helicobacter pylori on
portal hypertension-related hepatic encephalopathy. Immunopharmacology and
Immunotoxicology, 39(2), pp.105-106.
Lee, S., Hayashi, H., Matsuzaki, H., Kumagai-Takei, N., Maeda, M., Yoshitome, K.,
Yamamoto, S., Hatayama, T., Nishimura, Y. and Otsuki, T., 2017. Silica-Induced
Immunotoxicity: Chronic and Aberrant Activation of Immune Cells. In Allergy and
Immunotoxicology in Occupational Health (pp. 15-26).
Li, Y., Lu, H., Gu, Y., Ning, Z., Cao, T., Chen, C., Hu, C. and Tao, M., 2017. Enhancement ofNK cells proliferation and function by Shikonin. Immunopharmacology and Immunotoxicology,
39(3), pp.124-130.
Mak, A., Johnston, A. and Uetrecht, J., 2017. Effects of immunization and checkpoint
inhibition on amodiaquine-induced liver injury. Journal of Immunotoxicology, 14(1), pp.89-94.
Mohammadalipour, A., Karimi, J., Khodadadi, I., Solgi, G., Hashemnia, M., Sheikh, N. andBahabadi, M., 2017. Dasatinib prevent hepatic fibrosis induced by carbon tetrachloride (CCl4)
via anti-inflammatory and antioxidant mechanism. Immunopharmacology andimmunotoxicology, 39(1), pp.19-27.
Nishimura, Y., Kumagai-Takei, N., Maeda, M., Matsuzaki, H., Lee, S., Yamamoto, S.,
Hatayama, T., Yoshitome, K. and Otsuki, T., 2017. Suppressive Effects of Asbestos Exposureon the Human Immune Surveillance System. In Allergy and Immunotoxicology in Occupational
Health (pp. 1-14).
Pedata, P., Corvino, A.R., Lamberti, M., Petrarca, C., Di Giampaolo, L., Sannolo, N. and Di
Gioacchino, M., 2017. Non Pulmonary Effects of Isocyanates. In Allergy and
Immunotoxicology in Occupational Health (pp. 129-141).
.
June
2017

16

Immunotoxicology Specialty Section

Recent Immunology Publications:
General Immunotoxicology, cont.
Rushing, B.R., Hu, Q., Franklin, J.N., McMahen, R.L., Dagnino, S., Higgins, C.P., Strynar,
M.J. and DeWitt, J.C., 2017. Evaluation of the Immunomodulatory Effects of 2, 3, 3, 3Tetrafluoro-2-(Heptafluoropropoxy)-Propanoate in C57BL/6 Mice. Toxicological Sciences,156(1), pp.179-189
Soria, E.A., Pérez, R.D., Queralt, I., Pérez, C.A. and Bongiovanni, G.A., 2017.
Immunotoxicological effects of arsenic bioaccumulation on spatial metallomics and cellularenzyme response in the spleen of male Wistar rats after oral intake. Toxicology Letters, 266,
pp.65-73.
Sun, C., Jiang, M., Zhang, L., Yang, J., Zhang, G., Du, B., Ren, Y., Li, X. and Yao, J., 2017.
Cycloastragenol mediates activation and proliferation suppression in concanavalin A-induced
mouse lymphocyte pan-activation model. Immunopharmacology and Immunotoxicology, 39(3),pp.131-139.
Tewari, P., Mandal, P., Roy, R., Asthana, S., Dwivedi, P.D., Das, M. and Tripathi, A., 2017. A
novel function of TLR4 in mediating the immunomodulatory effect of Benzanthrone, anenvironmental pollutant. Toxicology Letters.
Ustarroz-Cano, M., Garcia-Pelaez, I., Cervantes-Yepez, S., Lopez-Valdez, N. and Fortoul, T.I.,
2017. Thymic cytoarchitecture changes in mice exposed to vanadium. Journal of
immunotoxicology, 14(1), pp.9-14.
Wang, K.S., Li, J., Wang, Z., Mi, C., Ma, J., Piao, L.X., Xu, G.H., Li, X. and Jin, X., 2017.
Artemisinin inhibits inflammatory response via regulating NF-κB and MAPK signaling
pathways. Immunopharmacology and immunotoxicology, 39(1), pp.28-36.
Wu, Y., Jin, F., Wang, Y., Li, F., Ren, Z. and Wang, Y., 2017. In vitro and in vivo inhibitory
effects of 6-hydroxyrubiadin on lipopolysaccharide-induced inflammation.
Immunopharmacology and Immunotoxicology, 39(3), pp.107-116.
Xu, H., Medina, S., Lauer, F.T., Douillet, C., Liu, K.J., Hudson, L.G., Stýblo, M., Aleksunes,
L.M. and Burchiel, S.W., 2017. Efflux Transporters Regulate Arsenite-Induced Genotoxicity in
Double Negative and Double Positive T Cells. Toxicological Sciences.
Zhang, D., Li, H., Geng, J., Li, Y., Li, S., Ma, C., Cong, B. and Zhang, X., 2017. The
therapeutic effects of cholecystokinin octapeptide on rat liver and kidney microcirculation
disorder in endotoxic shock. Immunopharmacology and immunotoxicology, 39(1), pp.2-10.
Methods/Models
Merly, L. and Smith, S.L., 2017. Murine RAW 264.7 cell line as an immune target: are we
missing something?. Immunopharmacology and Immunotoxicology, 39(2), pp.55-58.

June 201717

Immunotoxicology Specialty Section

Recent Immunology Publications:
Methods/Models, cont.
Phadnis-Moghe, A.S. and Kaminski, N.E., 2017. Immunotoxicity Testing using Human Primary
Leukocytes: An Adjunct Approach for the Evaluation of Human Risk. Current Opinion in
Toxicology.
Reviews/Books/Commentaries
Pallardy, M. and Bechara, R., 2017. Chemical or drug hypersensitivity: is the immune system
clearing the danger? Toxicological Sciences.
Parker, G.A. ed., 2017. Immunopathology in Toxicology and Drug Development: Volume 1,
Immunobiology, Investigative Techniques, and Special Studies. Springer.
Parker, G.A. ed., 2017. Immunopathology in Toxicology and Drug Development: Volume 2,
Organ Systems. Springer.

Save the Date!